fintepla
ucb pharma s.a. - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.
sertral filmuhúðuð tafla 50 mg
teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
sertral filmuhúðuð tafla 100 mg
teva b.v.* - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg
venlafaxin medical valley forðatafla 150 mg
medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg
venlafaxin medical valley forðatafla 300 mg
medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 300 mg
duloxetin w&h (duloxetini newline pharma) magasýruþolið hart hylki 30 mg
williams & halls ehf. - duloxetinum hýdróklóríð - magasýruþolið hart hylki - 30 mg
venlafaxin medical valley forðatafla 75 mg
medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 75 mg
sertralin bluefish filmuhúðuð tafla 50 mg
bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
sertralin wh filmuhúðuð tafla 100 mg
williams & halls ehf - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg
sertralin bluefish filmuhúðuð tafla 100 mg
bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg